Aimeike (300896.SZ): “Medical cross-linked sodium hyaluronate - hydroxypropyl methylcellulose gel” obtained a medical device registration certificate

Zhitong Finance App News, Aimeike (300896.SZ) issued an announcement. The company received the “People's Republic of China Medical Device Registration Certificate” issued by the State Drug Administration on July 29, 2026, involving the product: “Medical cross-linked sodium hyaluronate - hydroxypropyl methylcellulose gel”. The acquisition of the medical device registration certificate for the above products has further enriched the company's product matrix, is conducive to enhancing the company's core competitiveness, and will have a positive impact on the company's future development.